Vitamin D
Also called: cholecalciferol, vitamin D3.
Chapter 17 of The Cancer Evidence Handbook, Part Four. Last reviewed 2026-09-16. How this works.
Correcting a measured deficiency Grade C
Human evidence exists and does not settle it.
Vitamin D does not seem to stop people getting cancer, and whether it helps them live longer is disputed.
Null for cancer incidence. The mortality finding is contested.
How this grade was reached
The claim
The claim is that vitamin D prevents cancer and improves survival, and that most people are short of it. It is one of the most widely taken supplements in this book.
What it does
Vitamin D receptors are present in many tissues and the biology is genuinely interesting. This entry is graded on the trials, which are unusually large and unusually clear on one half of the question.
The evidence
On whether it prevents cancer, the answer is consistent and negative. Pooling ten randomised trials with 6,537 cancers gave a relative risk of 0.98 with no variation between trials, and a second pooled analysis across 81,362 participants gave 0.99. That result held across every subgroup examined.13
On mortality the picture is less settled. Pooled analyses suggested a reduction, and the one trial specifically designed to look at cancer mortality gave a risk ratio of 0.83 with an interval crossing one, falling to 0.75 when the first two years were excluded.132
A later review of twelve randomised trials across 72,669 participants concluded the opposite: supplementation did not reduce overall cancer mortality.4
A separate trial, in a population that already had enough vitamin D, found the trend running toward more cancer deaths rather than fewer.5
That last point is the one this chapter keeps finding, and it is the book’s reasoning rather than the finding of any single trial: what a supplement does depends on whether the person taking it was short of it to begin with. Correcting a measured deficiency and topping up someone who is already replete are different acts, and the trials do not always separate them.5
The studies this rests on
-
Pooled randomised trials of vitamin D and total cancer incidence1
A meta-analysis, summarising randomised trials, measured a clinical outcome.
no effect on total cancer incidence.
relative risk 0.98, interval 0.93 to 1.03. ten trials, 6,537 cases, no variation between trials
-
VITAL, vitamin D supplements and prevention of cancer2
A randomised trial, double blind, measured survival.
cancer mortality risk ratio below one with an interval crossing one.
risk ratio 0.83, interval 0.67 to 1.02. falling to 0.75, interval 0.59 to 0.96, when the first two years were excluded
What the evidence has not ruled out
In one large trial of people who already had enough vitamin D, cancer deaths trended higher rather than lower in those given more. The difference was not statistically certain, but it points the opposite way from the hope.5
The trend has also been questioned, because most of the extra deaths were recorded in the trial’s last two years, when causes of death were coded differently.6
Correcting a shortage and adding to a level that is already adequate are different things, which is why it is worth asking whether your own level has been measured.
What has not been shown
No trial in this record enrolled only people who were deficient. The claim graded here is about correcting a measured shortfall, and the trials tested supplementation in general populations.
This applies to: people with a measured deficiency specifically.
Established by trial scope, checked 2026-09-16. Result: the pooled trials enrolled general populations rather than people selected for deficiency.12
What to ask
Has my vitamin D been measured, and is it something you would want to treat?
When to call your team, and what to tell them
Whatever you are taking or thinking of taking, the people treating you can only weigh it if they know about it. That is true when nothing has been written down here, and it is most true then.
The register records no warning signs for vitamin D. That is not a statement that nothing can go wrong.
Find a trial instead
Correcting a measured deficiency is a clinical question for your own team rather than a trial question.
Search ClinicalTrials.gov for recruiting studies of vitamin D OR cholecalciferol
A trial is the same decision with monitoring, a known preparation and a doctor who knows what else you are taking.
Also recorded for this entry
Does it reach the body?
The register holds no comparison between a laboratory concentration and a blood level for vitamin D. This entry rests on randomised outcome trials rather than on a concentration argument. What that question means, for every compound here.
Does it clash with a cancer treatment?
The register holds no measured interaction between vitamin D and a cancer treatment class. Chapter 16 of the book covers supplement interactions in general, and an empty list here means nobody has measured this one. Nobody having looked is not the same as nothing being there.
Every recorded interaction, and how to turn it into a request for your pharmacist.
References
Keum N, Lee DH, Greenwood DC, Manson JE, Giovannucci E. Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials. Annals of Oncology 2019.
How this was reached: taken from the book's notes, chapter 17, note 6.
Manson JE, Cook NR, Lee IM, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. New England Journal of Medicine 2019;380(1):33-44.
How this was reached: taken from the book's notes, chapter 17, note 7. The author names are abbreviated in the source that was read, and have not been filled in here.
Zhang X, Niu W. Bioscience Reports 2019.
How this was reached: taken from the book's notes, chapter 17, note 6.
Zhang R, Zhang Y, Liu Z, Pei Y, Xu P, Chong W, Hai Y, He L, He Y, Yu J, Wang J, Fang F, Peng X. Association between vitamin D supplementation and cancer mortality: a systematic review and meta-analysis. Cancers 2022;14(15):3717.
doi:10.3390/cancers14153717 · PubMed 35954381 · PMC9367315
How this was reached: taken from the book's notes, chapter 17, note 8.
Neale RE, Baxter C, Romero BD, McLeod DSA, English DR, Armstrong BK, Ebeling PR, Hartel G, Kimlin MG, O’Connell R, van der Pols JC, Venn AJ, Webb PM, Whiteman DC, Waterhouse M. The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality. Lancet Diabetes and Endocrinology 2022;10(2):120-128.
doi:10.1016/S2213-8587(21)00345-4 · PubMed 35026158
How this was reached: taken from the book's notes, chapter 17, note 9.
Published letter on the D-Health Trial and the authors’ reply. Lancet Diabetes and Endocrinology 2022.
doi:10.1016/S2213-8587(22)00107-3 · PubMed 35461531
How this was reached: taken from the book's notes, chapter 17, note 9.